In a B16 melanoma model, MCMV-TRP2, a recombinant MCMV carrying an unmodified melanoma antigen (mouse tyrosinase-related protein 2 TRP2), induced prophylactic protection mediated by antibodies [111]. The gene discussed is DCT; the disease is melanoma.